Fosfomycin

08/01/2014 - "Both oral and intravenous fosfomycin formulations are effective for a wide range of gram-negative infections and disease severities; however, clinical studies are limited. "
03/01/1986 - "In this study, the clinical efficacy of fosfomycin (FOM) for various types of orofacial infections was evaluated in 40 patients, 27 males and 13 females, ranging in age from 16 to 71 years. "
03/01/2012 - "Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria."
03/01/1986 - "[Clinical efficacy of fosfomycin in the treatment of orofacial infections]."
11/01/2015 - "The aim of this study was to evaluate a role of fosfomycin therapy in the development of HUS in children who contracted STEC infection. "

10/01/2003 - "There were few important side effects with fosfomycin therapy and it was considered a safe and effective first line treatment in uncomplicated urinary tract infection."
01/01/2012 - "Oral treatment with fosfomycin tromethamine is effective against lower urinary tract infections (UTIs) caused by ESBL-producing Escherichia coli. "
05/01/1981 - "The efficacy of fosfomycin in urinary tract infections was investigated with a dose of 15 g/day. "
01/01/1969 - "Efficacy of phosphonomycin in treatment of urinary-tract infections."
05/01/2015 - "The aim this study was to determine the in vitro susceptibility to fosfomycin of bacteria isolated from urine samples of pregnant women with urinary tract infection. "

12/01/2015 - "Fosfomycin is recommended as first-line treatment for acute uncomplicated cystitis in women. "
12/01/2015 - "Of particular interest is fosfomycin, which is unrelated to other antibiotic classes and may take a more prominent role in treating MDRO cystitis."
08/01/2012 - "Fosfomycin is a wide-spectrum antibiotic that is used clinically to treat acute cystitis in the United States. "
09/01/2010 - "In the era of high drug resistance rates, reported even among community-acquired uropathogens, fosfomycin may provide a valuable alternative option for the treatment of cystitis in non-pregnant and pregnant women and in elderly and paediatric patients."
04/01/2010 - "In USA, the Food and Drug Administration (FDA) has approved fosfomycin only for the treatment of patients with uncomplicated cystitis. "

11/01/2011 - "combined with fosfomycin) is a promising treatment for MRSA endocarditis and warrants further investigation. "
01/01/1985 - "Experimental endocarditis and fosfomycin."
06/01/1988 - "Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus."
08/01/2012 - "aureus [MRSA] native-valve endocarditis) who were successfully treated with high-dose intravenous daptomycin (10 mg/kg/day) plus fosfomycin (2 g every 6 h) for 6 weeks. "
01/01/2011 - "High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report."

12/01/2015 - "Among 537 patients who received fosfomycin for any indication during this period, UTI was the most common indication (74%), followed by asymptomatic bacteriuria (10%). "
01/01/1977 - "Clinical bacteriological evaluation of infantile bacteriuria treated with fosfomycin."
01/01/1977 - "Fosfomycin in the bacteriuria of paraplegic patients."
06/01/2013 - "The aim of this study was to assess the efficacy of prophylactic fosfomycin tromethamine (FT) and ciprofloxacin in preventing bacteriuria caused by urodynamic studies (UDS). "
01/01/2015 - "The aim of this study was to evaluate oral single/multiple doses of Fosfomycin Trometamol with clinical and microbiological efficacy in:Asymptomatic bacteriuria in pregnancy.Endourological"